Andrew A. F. Hack, Director at Mersana Therapeutics, Inc. (MRSN]), bought 250,000 shares at $18.39 ($4.6M) on 2021-01-08, disclosed to the SEC on 2021-01-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.39 | 100,000 | $1.8M | 40.1% |
| 2 | $18.52 | 75,000 | $1.4M | 30.3% |
| 3 | $18.16 | 75,000 | $1.4M | 29.7% |
| Total | $18.36 avg | 250,000 | $4.6M | 100% |
| Filing → |
| DVAX | SELL | 2023-08-10 | $21.6M | — | Filing → |
| DVAX | SELL | 2023-06-16 | $6.3M | — | Filing → |
| DVAX | SELL | 2023-05-19 | $10.6M | — | Filing → |